Healthcare CMO Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The healthcare CMO market size is projected to reach US$ 385.26 billion by 2031 from US$ 138.24 billion in 2023. The market is expected to register a CAGR of 13.7% during 2023–2031. Growing market consolidation and rise in the mergers and acquisitions are likely to remain key trends in the market.

Healthcare CMO Market Analysis

Due to advances in biotechnology and innovative therapies, there is a growing demand for contract manufacturing organization (CMO) services in biopharmaceuticals and biologics. The rise of complex and specialized molecules, including highly potent drugs and personalized medicines, has increased the demand for CMOs with expertise in managing complex manufacturing processes. The healthcare CMO market is becoming increasingly global, and companies are seeking to partner with CMOs in different regions to benefit from cost efficiencies, regulatory advantages, and access to diverse markets.

Healthcare CMO Market Overview

CMOs provide services related to developing, manufacturing, and packaging pharmaceuticals, biotechnology products, medical devices, and other healthcare products. The healthcare industry is trending towards increasing outsourcing to CMOs. Companies leverage the expertise and skills of CMOs to streamline manufacturing processes and focus on core competencies. CMOs who offer flexible and scalable manufacturing solutions are in demand. Adapting to different production scales and schedules is critical for pharmaceutical and biotech companies.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Healthcare CMO Market: Strategic Insights

Healthcare CMO Market

• 
  CAGR (2023 - 2031)

  13.7%
• Market Size 2023
  US$ 138.24 Billion
• Market Size 2031
  US$ 385.26 Billion

Market Dynamics

GROWTH DRIVERS

• Increasing Inclination of Pharmaceutical and Medical Device Manufacturers Towards Outsourcing
• Rising Geriatric Population Coupled With The Increasing Production of Drugs & Medical Devices

FUTURE TRENDS

• Lack of Skilled Professionals for CMO

OPPORTUNITIES

• Rising Demand in Developing Regions

Key Players

• Royal DSM
• Catalent Inc
• Boehringer Ingelheim International GmbH
• Recipharm AB publ
• Fareva
• Lonza
• Piramal Enterprises Ltd
• Dr Reddy s Laboratories Ltd
• Almac Group
• FAMAR Health Care Services

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Service

• Pharmaceutical Contract Manufacturing Services
• Medical Device Contract Manufacturing Services

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Healthcare CMO Market Drivers and Opportunities

Rising Geriatric Population Coupled With The Increasing Production of Drugs & Medical Devices to Favor Market

The number of geriatric populations has been rising significantly across the world. According to the data published by the United Nations, the geriatric population is estimated to grow at a rate of 3% every year. Europe and Asia Pacific regions have the highest aged population of people 60 years and above. Further, the ageing population of the world is projected to reach from 1.4 billion in 2030 to 2.1 billion in 2050. Ageing has been linked with the various chronic diseases such as cardiovascular, diabetes, cancer and many more. Thereby, increasing the demand for the therapeutics products and the medical devices are increasing from these age groups are higher. Therefore, the above mentioned factors is expected to drive the market for the healthcare CMO owing to the rising demands globally.

Growth Opportunities Due to Rising Development of Biosimilars

The biosimilars are gaining attraction due to the apparent cost-savings that consumers hope to gain and opportunities for substitute pharmaceutical manufacturers to enter both established and emerging markets. Technological advancements and improvements for understanding any disease such as cancer, rheumatoid arthritis among others is leading to an increased demand for development of biosimilars and biologics. For fulfilling the unmet conditions many companies are heavily investing in biologics manufacturing that would generate higher revenues in return. The emerging countries such as China, India, Australia, and South Korea have the largest biotechnology hubs and are witnessing growth of the market due to the up-coming players. Therefore, the companies are preferring to outsource the manufacturing services to the CMOs so as to save in-house cost and time required for testing services during the development process of the biologics and biosimilars. This shift of preferring CMOs over in-house manufacturing is expected to increase the opportunity for the growth of the CMOs across the globe in the coming years.

Healthcare CMO Market Report Segmentation Analysis

Key segments that contributed to the derivation of the healthcare CMO market analysis is based on service.

• Based on service, the healthcare CMO market is bifurcated into pharmaceutical contract manufacturing services and medical device contract manufacturing services. The pharmaceutical contract manufacturing services is further categorized into active pharmaceutical ingredients (API), final dosage form manufacturing, and packaging. Similarly, the medical device contract manufacturing services is sub-segmented into outsourcing design, device manufacturing, and final good assembly. The pharmaceutical contract manufacturing services segment held the largest market share in 2023 and the same is expected to register highest CAGR during the forecast period.

Healthcare CMO Market Share Analysis by Geography

The geographic scope of the healthcare CMO market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the healthcare CMO market. The growth of the healthcare CMO market in North America are increase in the pharmaceutical, biopharmaceutical and medical devices industry, favorable conditions, and a well-regulated healthcare industry. The US held the largest market share in 2023. US is the largest market for the pharmaceutical and biopharmaceutical industry, the country accounts approximately one third of the global market. US is known as the leader in the world for the research and development activities in the biopharmaceutical. Moreover, the support from the government enhances the contract manufacturing for the pharmaceutical and biopharmaceuticals. This helps to push companies toward the development of drugs, countermeasures, and relate diagnostics estimated that are necessary for the public health and safety. In addition, an increase in complex device manufacturing has provided freedom from the day-to-day concerns and allows to put more focus and efforts for the company’s core technology that boosts market growth in the region.

Healthcare CMO Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Healthcare CMO Market News and Recent Developments

The healthcare CMO market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the healthcare CMO market are listed below:

• Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organization Aenova Group from leading international investment firm BC Partners. As part of the transaction, BC Partners’ advised funds will reinvest alongside Kühne Holding AG and continue to support Aenova as a minority shareholder. Financial terms were not disclosed. The Aenova Group is one of the world's leading CDMOs (Contract Development and Manufacturing Organizations) in the pharmaceutical and healthcare industry. (BC Partners, News, April 2024)
• Pharmascience, the largest Canadian-owned pharmaceutical company, announced a major US$ 120 million sterile injectable manufacturing facility expansion at its Candiac site. Following this important milestone, the company is now proud to announce the expansion of its contract development and manufacturing organization (CDMO) services with the creation of a new business unit dedicated to injectable products. (Pharmascience Inc., News, February 2024)
• Danaher Corporation announced a definitive agreement to acquire privately-held Aldevron, for cash purchase price of approximately US$ 9.6 billion, Danaher expects to finance the acquisition using cash on hand and/or proceed from the issuance of commercial paper. (Danaher Corporation, Press Release, June 2021)

Healthcare CMO Market Report Coverage and Deliverables

The “Healthcare CMO Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Healthcare CMO market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Healthcare CMO market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Healthcare CMO market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the healthcare CMO market
• Detailed company profiles